Project description
Diabetes management, just a breath away
Trained sniffer dogs can be used to detect people with high and low blood glucose, cancer and COVID-19. Inspired by the power of a dog’s nose, the Lassie breath analyser is a new device by the European Innovation Council BOYDSence. It’s the first non-invasive diabetes monitoring technology to use breath-based biomarkers to predict glucose levels. Current glucose monitoring technologies are underused because they are highly invasive, expensive, stigmatising and generate a lot of waste. With Lassie, all users need is to download a smartphone app and breathe into the device. By analysing volatile organic compounds in the breath, Lassie will calculate blood glucose value within current accuracy standards. Users will test earlier and more.
Fields of science
- natural scienceschemical sciencesorganic chemistryvolatile organic compounds
- agricultural sciencesanimal and dairy sciencedomestic animals
- medical and health sciencesclinical medicineendocrinologydiabetes
- medical and health scienceshealth sciencesinfectious diseasesRNA virusescoronaviruses
- medical and health sciencesclinical medicineoncology
Programme(s)
Funding Scheme
HORIZON-AG - HORIZON Action Grant Budget-BasedCoordinator
31500 Toulouse
France
See on map